Insight

Laura Bukavina discusses a paper on BCG treatment for patients with urothelial carcinoma of the prostatic urethra

Laura Bukavina/X

Jan 20, 2025, 04:14

Laura Bukavina discusses a paper on BCG treatment for patients with urothelial carcinoma of the prostatic urethra

Laura Bukavina, Urologic Oncologist at Cleveland Clinic Urology, shared a post on X about a recent paper by Ryo Yamashita et al. published in World Journal of Urology:

“49% of patients with UC of the prostatic urethra experienced high recurrence at 5 years after BCG treatment vs 23% for bladder(HR 2.74). Progression to MIBC/metastasis 26% vs. 5% (HR 5.75). Early cystectomy should be a key consideration.”

“Clinical outcome of BCG treatment for patients with urothelial carcinoma of the prostatic urethra: Implications for early cystectomy”

Authors: Ryo Yamashita, Takashi Sugino, Akifumi Notsu, Kana Ito, Yuma Sakura, Hideo Shinsaka, Masato Matsuzaki, Masashi Niwakawa and Eiji Kikuchi.

More posts featuring Laura Bukavina.

Akifumi Notsu BCG treatment cancer Eiji Kikuchi Hideo Shinsaka Kana Ito Laura Bukavina Masashi Niwakawa Masato Matsuzaki OncoDaily Oncology Ryo Yamashita Takashi Sugino urothelial carcinoma Yuma Sakura

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success